Literature DB >> 27365579

PHARMACOLOGICAL THERAPY OF ERECTILE DYSFUNCTION.

M K Garg1, J S Saini2.   

Abstract

Keywords:  Erectile dysfunction; Therapy

Year:  2011        PMID： 27365579      PMCID： PMC4925039          DOI： 10.1016/S0377-1237(01)80091-5

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  18 in total

1.  Characterization of contraction-mediating prostanoid receptors in human penile erectile tissues.

Authors:  H Hedlund; K E Andersson; M Fovaeus; F Holmquist; T Uski
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

2.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Authors:  I Goldstein; T F Lue; H Padma-Nathan; R C Rosen; W D Steers; P A Wicker
Journal:  N Engl J Med       Date:  1998-05-14       Impact factor: 91.245

Review 3.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

4.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

Authors:  R C Rosen; A Riley; G Wagner; I H Osterloh; J Kirkpatrick; A Mishra
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

Review 5.  Hemodynamics of penile erection.

Authors:  S R Aboseif; T F Lue
Journal:  Urol Clin North Am       Date:  1988-02       Impact factor: 2.241

Review 6.  NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence.

Authors: 
Journal:  JAMA       Date:  1993-07-07       Impact factor: 56.272

7.  Sildenafil, a novel effective oral therapy for male erectile dysfunction.

Authors:  M Boolell; S Gepi-Attee; J C Gingell; M J Allen
Journal:  Br J Urol       Date:  1996-08

8.  Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Authors:  M Boolell; M J Allen; S A Ballard; S Gepi-Attee; G J Muirhead; A M Naylor; I H Osterloh; C Gingell
Journal:  Int J Impot Res       Date:  1996-06       Impact factor: 2.896

9.  Impotence in medical clinic outpatients.

Authors:  M F Slag; J E Morley; M K Elson; D L Trence; C J Nelson; A E Nelson; W B Kinlaw; H S Beyer; F Q Nuttall; R B Shafer
Journal:  JAMA       Date:  1983-04-01       Impact factor: 56.272

10.  The unreliability of nocturnal penile tumescence recording as an outcome measurement in the treatment of organic impotence.

Authors:  M Condra; A Morales; D H Surridge; J A Owen; P Marshall; J Fenemore
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.